Sitagliptin phosphate monohydrate is an active pharmaceutical ingredient used in the manufacturing of medications for type 2 diabetes. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, increasing insulin production and decreasing glucagon production by the pancreas.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 654671-78-0
Sitagliptin monohydrochloride monohydrate
active pharmaceutical ingredient
Sitagliptin tartrate hemihydrate
active pharmaceutical ingredient
Sitagliptin Hydrochloride
active pharmaceutical ingredient
Sitagliptin
Dipeptidyl peptidase IV inhibitor
NAFTIFINE HYDROCHLORIDE
allylamine antifungal active pharmaceutical ingredient
Inositol hexanicotinate
Active pharmaceutical ingredient
Asenapin
active pharmaceutical ingredient
4'-Demethylepipodophyllotoxin
antineoplastic agent
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate
GQPYTJVDPQTBQC-KLQYNRQASA-N
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.O.OP(=O)(O)O